Left Ventricular Assist Device Clinical Trials

The heart failure and cardiothoracic surgery clinical trials team is interested in seeing how exciting new left ventricular assist devices (LVAD) can help to improve the outcomes and quality of life for those living with heart failure  and other cardiovascular diseases which require LVADs.

Feel free to call or e-mail the Knight Cardiovascular Institute research team at 503-518-1964 or by emailing heartresearch@ohsu.edu. You will then be forwarded to the appropriate research team member who will be able to see if you qualify for any of the clinical trials being offered at OHSU. 

You can also find all the of heart failure clinical trials, that are currently enrolling patients, below. 


Multi-Center Study oMaglev Technology in Patients Undergoing MCS Therapy in HeartMate 3

Primary investigator:

Frederick Tibayan, M.D.

Protocol number:


Study purpose:

The purpose of this study is to evaluate the effect of the investigational drug, mavacamten, compared to a placebo (an inactive drug) in patients with non-obstructive HCM. This is being done to confirm that mavacamten is safe, and can be tolerated and to study whether it helps to improve symptoms or ability to exercise.


John Halvorson (Study Coordinator)